$SNPS

Synopsys Stock Rises 9%

Synopsys (SNPS) stock rose 9.38% to $475.74 on Thursday, following a strategic partnership with OpenAI to develop GPT-Synopsys, an AI model for semiconductor design. The company's stock traded between $462.00 and $493.30 with higher-than-average volume. The 52-week range is $362.55 to $539.48.

Original reporting
Published Oct 1, 2026, 4:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 5:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Synopsys Stock Rises 9% — source image
Decision brief

The 30-second read

$SNPSBullishHigh
01

Why it matters

The OpenAI partnership could accelerate AI integration in chip design, potentially expanding Synopsys' addressable market.

02

Market read

A 9% intraday rally on a strategic AI partnership signals strong investor interest in AI‑enabled EDA solutions.

03

What to watch

Details of revenue sharing and the financial size of the deal were not disclosed, leaving upside potential uncertain.

Relevance 7/10Novelty 8/10Timing: today

Background

Synopsys is a leading provider of electronic design automation (EDA) software used in semiconductor chip design.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Shares rose 9.38% to $475.74 after Synopsys announced a multi‑year partnership with OpenAI to develop GPT‑Synopsys.

Expected impact

upward pressure as investors price in AI growth potential

Evidence & confidence

A fresh, material partnership with a leading AI firm triggered a double‑digit intraday rally, indicating strong market enthusiasm.

Market effects

Strengthens the AI‑enabled semiconductor design sector and may boost related EDA vendors.

Positive for US tech stocks, especially those with AI collaborations.

Highlights growing convergence of AI and semiconductor design worldwide.

Counterpoint

If the partnership fails to deliver measurable efficiency gains, the rally could be short‑lived.

Key entities

  • Synopsys, Inc.

    US‑listed EDA software provider.

  • OpenAI

    AI research and deployment organization.

Related articles

$ACNMed

Stocks making the biggest moves midday: Accenture, Synopsys, United Therapeutics, Vicor and more

Accenture rose 18% after Q4 revenue of $18.7B beat estimates. McCormick's Q3 results topped expectations but shares fell 2% amid Unilever's acquisition. McKesson gained 4% on reaffirmed guidance and a CVS Health partnership. United Therapeutics climbed 6% after a court ruling, while Liquidia dropped 15%. Constellation Energy gained 3% on a 20-year Amazon deal. Synopsys jumped 8% with 2027 revenue targets. Sigma Lithium slid 16% after halting production.

$SNPSHighAI 9/10

Why Synopsys Stock Soared on Thursday

Synopsys (SNPS) stock rose 12.5% after the company projected 2027 revenue up to $11.2B, higher than analysts' $9.7B estimate for 2026. It expects 2027 free cash flow of $3.1B and operating margins of 20.7%. GAAP EPS is forecast at $8.16-$8.61, while non-GAAP EPS is projected at $19.04-$19.12.

$SNPSMedAI 8/10

Synopsys Stock Jumps As AI Deals And Targets Power SNPS

Synopsys Inc. (NASDAQ: SNPS) stock rose 9.91% on October 1, 2026, driven by strong AI-chip design demand and upbeat guidance. The company reported $7.05B in trailing revenue, 72% gross margin, and guided to 15% annual revenue growth, targeting $11.15B in FY27. Recent partnerships with Amazon, OpenAI, and TSMC bolster its AI and chip design narrative. HSBC upgraded SNPS to Buy with a $700 target.

$SNPSHighAI 8/10

Synopsys Stock Jumps As AI Deals And Targets Impress Wall Street

Synopsys Inc. (NASDAQ: SNPS) shares rose 10.06% on October 1, 2026, driven by strong AI-chip design demand and upbeat guidance. The company reported $7.05B in revenue, 72.4% gross margin, and 30%+ EBITDA margin. SNPS projected 15% revenue growth for FY27, targeting $11.15B, and announced AI partnerships with Amazon and OpenAI. HSBC upgraded SNPS to Buy with a $700 target, citing high-growth AI potential.